Submitted by admin on Mon, 11/30/2020 - 00:00

Dealings in securities by prescribed officers of Sasol and directors of major subsidiaries of Sasol

Sasol Limited
(Incorporated in the Republic of South Africa)
(Registration number 1979/003231/06)
Sasol Ordinary Share codes: JSE: SOL NYSE: SSL
Sasol Ordinary ISIN codes: ZAE000006896 US8038663006
Sasol BEE Ordinary Share code: JSE: SOLBE1
Sasol BEE Ordinary ISIN code: ZAE000151817
(“Sasol” or “Company”)

DEALINGS IN SECURITIES BY PRESCRIBED OFFICERS OF SASOL AND DIRECTORS OF
MAJOR SUBSIDIARIES OF SASOL

In compliance with paragraph 3.63 to 3.66 of the JSE Limited Listings Requirements (“Listings
Requirements”), Sasol hereby announces that prescribed officers of Sasol, and directors of major
subsidiaries of Sasol have, in terms of the Sasol Long-Term Incentive (“LTI”) Plan (“Plan”), been
issued shares in terms of previously accepted LTI awards as follows:

- 2015 award (balance vested) at the achievement of corporate performance targets of 47%
(GEC) and 68,2% (SVP and lower) respectively, which were achieved over the performance
period 2015 - 2018. The balance of 50% of these vested shares were subject to a 2-year
retention period from 2018 - 2020.
- 2017 (50% of the vested award): at the achievement of corporate performance targets of 26%
(GEC) and 56% (SVP and lower) respectively, which were achieved over the performance
period 2017 - 2020. The balance of these shares (after application of the performance targets),
will vest in 2022 subject to the rules of the Plan.

Participants have the option to retain all shares, sell sufficient shares to cover the tax liability and
retain the balance of shares or to sell the vested shares. The dealings are as set out below.

Vesting date: 6 October 2020
Class of shares: Sasol American Depositary Receipts (ADR) each representing one
Sasol ordinary share
Initial issue price per right: USD0,00
Nature of Transaction: Retention of vested shares off-market
Nature and extent of interest: Direct beneficial

Surname and Designation Company Number Price per Total value of
initials of shares share the
(USD) transaction
(USD)
Griffith, B V Prescribed Officer Sasol Limited 3 056 7,42 22 675,52
Director Sasol (USA) Corporation
Harris, J R Prescribed Officer Sasol Limited 1 466 7,42 10 877,72
Thomas, M S Director Sasol (USA) Corporation 2 724 7,42 20 212,08
Sasol Chemicals (USA)
LLC

Vesting date: 6 October 2020
Transaction date: 27 November 2020
Class of shares: Sasol American Depositary Receipts (ADR) each representing one
Sasol ordinary share
Initial issue price per right: USD0,00
Nature of Transaction: Sale of vested shares on-market to cover the tax liability on the
vested shares
Nature and extent of interest: Direct beneficial

Surname and Designation Company Number Average Total value of
initials of Selling the
shares Price per transaction
share* (USD)
(USD)
Harris, J R Prescribed Officer Sasol Limited 1 410 8,59 12 111,90
Thomas, M S Director Sasol (USA) Corporation 2 367 8,59 20 332,53
Sasol Chemicals (USA)
LLC
* Average selling price per share is based on transactions effected by the Company on 27 November 2020. Proceeds are allocated to the
shares sold by directors, as with all employees, based on the outcome of the bulk sale.

The highest and lowest prices, as well as VWAP price for the day of trading are as follows:

Date Highest Lowest price Volume Weighted Average
price Price
27 November 2020 8,72 8,37 8,59

In terms of paragraph 3.66 of the Listings Requirements, the necessary clearance to deal has been
obtained for all the transactions set out above.

30 November 2020
Sandton

Sponsor: Merrill Lynch South Africa Proprietary Limited

Date: 30-11-2020 05:32:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.

Ticker
SOL,SOLBE1
Headline Date
Publish Time
17:32:00
Source
Johannesburg Stock Exchange - SENS NEWS DELAYED
Year
2020

Dealings in securities by prescribed officers of Sasol and directors of major subsidiaries of Sasol

Sasol Limited
(Incorporated in the Republic of South Africa)
(Registration number 1979/003231/06)
Sasol Ordinary Share codes: JSE: SOL NYSE: SSL
Sasol Ordinary ISIN codes: ZAE000006896 US8038663006
Sasol BEE Ordinary Share code: JSE: SOLBE1
Sasol BEE Ordinary ISIN code: ZAE000151817
(“Sasol” or “Company”)

DEALINGS IN SECURITIES BY PRESCRIBED OFFICERS OF SASOL AND DIRECTORS OF
MAJOR SUBSIDIARIES OF SASOL

In compliance with paragraph 3.63 to 3.66 of the JSE Limited Listings Requirements (“Listings
Requirements”), Sasol hereby announces that prescribed officers of Sasol, and directors of major
subsidiaries of Sasol have, in terms of the Sasol Long-Term Incentive (“LTI”) Plan (“Plan”), been
issued shares in terms of previously accepted LTI awards as follows:

- 2015 award (balance vested) at the achievement of corporate performance targets of 47%
(GEC) and 68,2% (SVP and lower) respectively, which were achieved over the performance
period 2015 - 2018. The balance of 50% of these vested shares were subject to a 2-year
retention period from 2018 - 2020.
- 2017 (50% of the vested award): at the achievement of corporate performance targets of 26%
(GEC) and 56% (SVP and lower) respectively, which were achieved over the performance
period 2017 - 2020. The balance of these shares (after application of the performance targets),
will vest in 2022 subject to the rules of the Plan.

Participants have the option to retain all shares, sell sufficient shares to cover the tax liability and
retain the balance of shares or to sell the vested shares. The dealings are as set out below.

Vesting date: 6 October 2020
Class of shares: Sasol American Depositary Receipts (ADR) each representing one
Sasol ordinary share
Initial issue price per right: USD0,00
Nature of Transaction: Retention of vested shares off-market
Nature and extent of interest: Direct beneficial

Surname and Designation Company Number Price per Total value of
initials of shares share the
(USD) transaction
(USD)
Griffith, B V Prescribed Officer Sasol Limited 3 056 7,42 22 675,52
Director Sasol (USA) Corporation
Harris, J R Prescribed Officer Sasol Limited 1 466 7,42 10 877,72
Thomas, M S Director Sasol (USA) Corporation 2 724 7,42 20 212,08
Sasol Chemicals (USA)
LLC

Vesting date: 6 October 2020
Transaction date: 27 November 2020
Class of shares: Sasol American Depositary Receipts (ADR) each representing one
Sasol ordinary share
Initial issue price per right: USD0,00
Nature of Transaction: Sale of vested shares on-market to cover the tax liability on the
vested shares
Nature and extent of interest: Direct beneficial

Surname and Designation Company Number Average Total value of
initials of Selling the
shares Price per transaction
share* (USD)
(USD)
Harris, J R Prescribed Officer Sasol Limited 1 410 8,59 12 111,90
Thomas, M S Director Sasol (USA) Corporation 2 367 8,59 20 332,53
Sasol Chemicals (USA)
LLC
* Average selling price per share is based on transactions effected by the Company on 27 November 2020. Proceeds are allocated to the
shares sold by directors, as with all employees, based on the outcome of the bulk sale.

The highest and lowest prices, as well as VWAP price for the day of trading are as follows:

Date Highest Lowest price Volume Weighted Average
price Price
27 November 2020 8,72 8,37 8,59

In terms of paragraph 3.66 of the Listings Requirements, the necessary clearance to deal has been
obtained for all the transactions set out above.

30 November 2020
Sandton

Sponsor: Merrill Lynch South Africa Proprietary Limited

Date: 30-11-2020 05:32:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.